HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease.

Abstract
Paraoxonase 1 (PON1) activity is consistently predictive of vascular disease, although the genotype at four functional PON1 polymorphisms is not. To address this inconsistency, we investigated the role of all common PON1 genetic variability, as measured by tagging single-nucleotide polymorphisms (tagSNPs), in predicting PON1 activity for phenylacetate hydrolysis, LDL susceptibility to oxidation ex vivo, plasma homocysteine (Hcy) levels, and carotid artery disease (CAAD) status. The biological goal was to establish whether additional common genetic variation beyond consideration of the four known functional SNPs improves prediction of these phenotypes. PON2 and PON3 tagSNPs were secondarily evaluated. Expanded analysis of an additional 26 tagSNPs found evidence of previously undescribed common PON1 polymorphisms that affect PON1 activity independently of the four known functional SNPs. PON1 activity was not significantly correlated with LDL oxidative susceptibility, but genotypes at the PON1(-108) promoter polymorphism and several other PON1 SNPs were. Neither PON1 activity nor PON1 genotype was significantly correlated with plasma Hcy levels. This study revealed previously undetected common functional PON1 polymorphisms that explain 4% of PON1 activity and a high rate of recombination in PON1, but the sum of the common PON1 locus variation does not explain the relationship between PON1 activity and CAAD.
AuthorsChristopher S Carlson, Patrick J Heagerty, Thomas S Hatsukami, Rebecca J Richter, Jane Ranchalis, Julieann Lewis, Tamara J Bacus, Laura A McKinstry, Gerard D Schellenberg, Mark Rieder, Deborah Nickerson, Clement E Furlong, Alan Chait, Gail P Jarvik
JournalJournal of lipid research (J Lipid Res) Vol. 47 Issue 5 Pg. 1014-24 (May 2006) ISSN: 0022-2275 [Print] United States
PMID16474172 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Lipoproteins, LDL
  • Homocysteine
  • Esterases
  • Aryldialkylphosphatase
  • PON1 protein, human
  • PON2 protein, human
  • PON3 protein, human
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Aryldialkylphosphatase (genetics, metabolism)
  • Carotid Stenosis (genetics)
  • Esterases
  • Genetic Techniques
  • Haplotypes
  • Homocysteine (blood)
  • Humans
  • Lipoproteins, LDL (metabolism)
  • Male
  • Middle Aged
  • Oxidation-Reduction
  • Polymorphism, Single Nucleotide (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: